Bio-Rad Laboratories, BioSource deal

BIO proposed to acquire the 95% of BIOI it does not already own for $8.50 per share in cash. The deal price is a 26% premium to BIOI’s April 6 close of $6.75 and values the company at $81.3 million. B...